secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K/A
Filed at:   2023-10-24T23:59:59+00:00
Accession:  0001493152-23-038156
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Biotherapeutics appoints Alan R. Stewart as Class I director
-------------------------------------------------------------------

- Alan R. Stewart appointed Class I director effective October 10, 2023.
- He also joined the Audit Committee and Compensation Committee.
- Received options to purchase 52,500 shares at $3.32 per share.
- Stewart is CFO of Soundthinking, Inc. with M&A and finance expertise.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315223038156/0001493152-23-038156-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315223038156/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-038156

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer